Every finding on record at Aspire Home Health Care Services LLC

EMERGENCY PREPAREDNESS At the time of the emergency preparedness survey completed on 03/31/23, Aspire Home Health Care is in compliance with the provisions of 42 CFR Part. 484.102.

Partial Extended Recertification Survey The following deficiencies are based on the partial extended standard recertification survey completed on 03/31/23.

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on record review, interview with patient family, policy review and staff interview, the agency failed to ensure the medications taken by the patient matched the current medication profile. This affected one (Patient #3) of three patients reviewed with home visits. The agency census was 63. Review of the record revealed Patient # 3 had a start of care (SOC) on 02/17/23 with the certification period reviewed of 02/17/23-04/17/23. The primary diagnosis was listed as a C5 spinal cord injury with pressure ulcers. Listed on the plan of care (POC) and medication profile was the cardiac medication lisinopril 10 milligram (mg) once per day per a gastric tube and the blood thinner rivaroxaban 10 mg one per day. A home visit was completed with Staff C on 03/29/23. Interview with Patient #3's father at the time of the home visit revealed the lisinopril was stopped sometime ago and the rivaroxaban was changed to Eloquis 2.5 mg while in the hospital and before the start of care. Review of the facility policy titled "Medical Record Content," revealed the agency will provide an accurate and current medical record for every patient seen by the agency. This policy further stated a current medication profile to include medication/allergies/sensitivities, education, dose, frequency and route of administration for prescription and non-prescription medications. Interview with Staff A 03/30/23 at 12:50 PM verified medications which were discontinued prior to the SOC were listed as current on the POC. Staff A also verified new medications such as Eloquis 2.5 mg were not listed on the POC or medication profile.